OBJECTIVE: To examine the risk of fracture in patients with multiple sclerosis (MS) compared with population-based controls. METHODS: A population-based cohort study was performed in the Dutch PHARMO Record Linkage System (1998-2008). Patients with MS (n = 2,415) were matched by year of birth, sex, and practice to up to 6 patients without MS (controls). We used Cox proportional hazards models to estimate the hazard ratio (HR) of fracture in MS. Time-dependent adjustments were made for age, history of disease, and drug use. RESULTS: During follow-up, there were 59 fractures among patients with MS (2.4%) and 227 fractures among controls (1.8%). Patients with MS had a 1.7-fold increased risk of osteoporotic fracture (HR 1.73 [95% confidence interval (CI) 1.18-2.53]) and a 4-fold increased risk of hip fracture (HR 4.08 [95% CI 2.21-7.56]). The risk of osteoporotic fracture was significantly greater for patients with MS who had been prescribed antidepressants (HR 3.25 [95% CI 1.77-5.97]) or hypnotics/anxiolytics (HR 3.40 [95% CI 2.06-5.63]) in the previous 6 months, compared with controls. CONCLUSIONS: Increased awareness of the risk of hip fracture is warranted in patients with MS, especially in those who have recently been prescribed antidepressants or hypnotics/anxiolytics.
OBJECTIVE: To examine the risk of fracture in patients with multiple sclerosis (MS) compared with population-based controls. METHODS: A population-based cohort study was performed in the Dutch PHARMO Record Linkage System (1998-2008). Patients with MS (n = 2,415) were matched by year of birth, sex, and practice to up to 6 patients without MS (controls). We used Cox proportional hazards models to estimate the hazard ratio (HR) of fracture in MS. Time-dependent adjustments were made for age, history of disease, and drug use. RESULTS: During follow-up, there were 59 fractures among patients with MS (2.4%) and 227 fractures among controls (1.8%). Patients with MS had a 1.7-fold increased risk of osteoporotic fracture (HR 1.73 [95% confidence interval (CI) 1.18-2.53]) and a 4-fold increased risk of hip fracture (HR 4.08 [95% CI 2.21-7.56]). The risk of osteoporotic fracture was significantly greater for patients with MS who had been prescribed antidepressants (HR 3.25 [95% CI 1.77-5.97]) or hypnotics/anxiolytics (HR 3.40 [95% CI 2.06-5.63]) in the previous 6 months, compared with controls. CONCLUSIONS: Increased awareness of the risk of hip fracture is warranted in patients with MS, especially in those who have recently been prescribed antidepressants or hypnotics/anxiolytics.
Authors: C L Gregson; E M Dennison; J E Compston; S Adami; J D Adachi; F A Anderson; S Boonen; R Chapurlat; A Díez-Pérez; S L Greenspan; F H Hooven; A Z LaCroix; J W Nieves; J C Netelenbos; J Pfeilschifter; M Rossini; C Roux; K G Saag; S Silverman; E S Siris; N B Watts; A Wyman; C Cooper Journal: Osteoporos Int Date: 2013-07-25 Impact factor: 4.507
Authors: Tingting Zhang; Andrew R Zullo; Theresa I Shireman; Yoojin Lee; Vincent Mor; Qing Liu; Kevin W McConeghy; Lori Daiello; Douglas P Kiel; Sarah D Berry Journal: Disabil Health J Date: 2018-03-21 Impact factor: 2.554
Authors: Chelsea A Pelletier; Frédéric S Dumont; Jean Leblond; Luc Noreau; Lora Giangregorio; B Catharine Craven Journal: Top Spinal Cord Inj Rehabil Date: 2014
Authors: H M Colhoun; S J Livingstone; H C Looker; A D Morris; S H Wild; R S Lindsay; C Reed; P T Donnan; B Guthrie; G P Leese; J McKnight; D W M Pearson; E Pearson; J R Petrie; S Philip; N Sattar; F M Sullivan; P McKeigue Journal: Diabetologia Date: 2012-09-04 Impact factor: 10.122